Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.54T | 1.21T | 1.02T | 936.66B | 791.75B | Gross Profit |
2.54T | 1.21T | 1.02T | 936.66B | 791.75B | EBIT |
1.02T | 661.56B | 518.56B | 439.80B | 365.75B | EBITDA |
1.05T | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
640.62B | 495.45B | 386.00B | 325.98B | 260.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
631.76B | 7.24T | 5.99T | 5.32T | 4.13T | Total Assets |
44.12T | 25.76T | 21.11T | 17.98T | 15.96T | Total Debt |
7.31T | 3.24T | 2.19T | 1.48T | 1.47T | Net Debt |
5.02T | 878.07B | 587.42B | 443.06B | 742.81B | Total Liabilities |
36.23T | 22.84T | 18.60T | 15.82T | 14.07T | Stockholders Equity |
4.56T | 2.91T | 2.50T | 2.16T | 1.89T |
Cash Flow | Free Cash Flow | |||
147.83B | 433.58B | 554.69B | 903.97B | 152.89B | Operating Cash Flow |
190.69B | 477.20B | 581.02B | 921.78B | 171.18B | Investing Cash Flow |
53.14B | -4.39T | -3.30T | -2.52T | -2.15T | Financing Cash Flow |
3.35T | 4.17T | 2.91T | 1.92T | 1.85T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $171.96B | 7.99 | 13.74% | 5.86% | 6.79% | 8.57% | |
77 Outperform | $119.54B | 19.57 | 17.89% | 0.61% | 22.15% | 12.13% | |
73 Outperform | $172.51B | 21.81 | 14.51% | 0.82% | 13.13% | 0.54% | |
67 Neutral | $204.11B | 11.23 | 11.05% | 2.22% | 3.22% | 16.51% | |
65 Neutral | $140.77B | 11.50 | 9.70% | 1.92% | 13.21% | -12.06% | |
64 Neutral | $116.02B | 10.37 | 6.33% | 3.23% | 2.97% | 88.51% | |
63 Neutral | $12.37B | 9.56 | 7.95% | 79.17% | 12.62% | -5.26% |